Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J; Cortés J; Kim SB; Im SA; Hegg R; Im YH; Roman L; Pedrini JL; Pienkowski T; Knott A; Clark E; Benyunes MC; Ross G; Swain SM; The New England Journal Of Medicine, 2012, vol. 366, issue 2, p 109, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation